#United States #Inc. #Health Products #ivWatch #Newport News

ivWatch Celebrates Recognition in Inc.'s 2024 Best in Business List

ivWatch, LLC, a pioneer in IV safety solutions, has an exciting announcement — the company has been named to Inc.'s 2024 Best in Business list in the Health Products category. This honor recognizes outstanding companies that bring meaningful impact to their respective industries and society overall.

Inc.'s evaluation process highlights not only growth metrics but also the influence these companies impart in their sectors. This year, ivWatch stands among elite peers from diverse industries, including technology, finance, and healthcare.

The accolade follows over 20 years of dedicated research and development aimed at enhancing IV safety standards globally. Since its inception, ivWatch has secured an impressive 69 patents related to its groundbreaking technology. To date, the company has monitored over 300,000 patients and has logged an astounding 9 million hours of patient monitoring.

In 2023 alone, ivWatch experienced a significant surge in its product demand, with single-use sensor sales up an impressive 83% compared to the previous year. The company's expansion is notable, spreading its advanced technology beyond U.S. borders to countries including the U.K., Ireland, the Netherlands, and many others. This international growth reflects accolades from customers and healthcare professionals alike, who recognize the critical need for enhanced IV safety solutions.

Furthermore, ivWatch has seen a remarkable 430% increase in product evaluations completed from the first half of 2023 to the same period in 2024, indicating a growing consensus on the effectiveness of their products. The breadth of evaluations has expanded from merely two countries to 13 countries within this time span, highlighting the increasing global interest in ivWatch's innovations.

Gary Warren, the CEO of ivWatch, expressed gratitude for the recognition, stating, “This award is a testament to the hard work and commitment of the entire ivWatch team. We are on a mission to tackle one of healthcare's most pressing issues — reducing IV-related injuries. This honor is a celebration of the dedicated team and our collaborative journey with customers towards enhancing patient safety.”

The Best in Business Awards are open to various types of companies across all sectors, encouraging public, private, and nonprofit organizations to apply. The selection process involves a thorough review by Inc. editors, ensuring that only those with substantial positive impacts on their communities and industries receive this prestigious accolade.

For over 40 years, Inc. has been a trusted source in recognizing business dynamism and the transformative efforts these companies undertake. This recognition places ivWatch not just among those innovating within healthcare but also within a broader community committed to making a difference.

For more details and to check out the complete list of honorees, visit inc.com/best-in-business.

About ivWatch, LLC

Established in 2010, ivWatch developed a pioneering Class II medical device designed to continuously monitor peripheral IVs. Leveraging visible and near-infrared light paired with advanced predictive algorithms, the ivWatch system enables real-time detection of IV infiltration and extravasation, a critical advancement given the severe consequences associated with these events. By performing over 18,000 checks per hour, the system alerts healthcare professionals to potential issues, thereby mitigating risks before serious complications arise.

In addition to its latest accolades, ivWatch has recently surpassed 30 clinical bodies of evidence and has been recognized in Fast Company's Most Innovative Companies for 2024, further solidifying its position as a leader in its field. The company continues to pave the way for advancements in medical device technologies aimed at significantly improving patient care.